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ABSTRACT Bacterial fatty acids are critical components of the cellular membrane. A
shift in environmental conditions or in the bacterium’s lifestyle may result in the
requirement for a distinct pool of fatty acids with unique biophysical properties. This
can be achieved by the modification of existing fatty acids or via de novo synthesis.
Furthermore, bacteria have evolved efficient means to acquire these energy-rich mole-
cules from their environment. However, the balance between de novo fatty acid syn-
thesis and exogenous acquisition during pathogenesis is poorly understood. Here, we
studied the mouse fatty acid landscape prior to and after infection with Acinetobacter
baumannii, a Gram-negative, opportunistic human pathogen. The lipid fluxes observed
following infection revealed fatty acid- and niche-specific changes. Lipidomic profiling
of A. baumannii isolated from the pleural cavity of mice identified novel A. baumannii
membrane phospholipid species and an overall increased abundance of unsaturated
fatty acid species. Importantly, we found that A. baumannii relies largely upon fatty
acid acquisition in all but one of the studied niches, the blood, where the pathogen
biosynthesizes its own fatty acids. This work is the first to reveal the significance of
balancing the making and taking of fatty acids in a Gram-negative bacterium during
infection, which provides new insights into the validity of targeting fatty acid synthesis
as a treatment strategy.
IMPORTANCE Acinetobacter baumannii is one of the world’s most problematic super-
bugs and is associated with significant morbidity and mortality in the hospital envi-
ronment. The critical need for new antimicrobial strategies is recognized, but our
understanding of its behavior and adaptation to a changing environment during
infection is limited. Here, we investigated the role of fatty acids at the host-pathogen
interface using a mouse model of disease. We provide comprehensive insights into
the bacterial membrane composition when the bacteria colonize the pleural cavity.
Furthermore, we show that A. baumannii heavily relies upon making its own fatty
acids when residing in the blood, whereas the bacterium favors fatty acid acquisition
in most other host niches. Our new knowledge aids in understanding the impor-
tance of host fatty acids in infectious diseases. Furthermore, fatty acid synthesis is an
attractive target for the development of new antimicrobial strategies, but our work
emphasizes the critical need to understand microbial lipid homeostasis before this
can be deemed suitable.
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The bacterial type II fatty acid synthesis (FASII) pathway has been interrogated as apotential antimicrobial target, with the validity of this strategy being debated through
studies of the Gram-positive bacterium Staphylococcus aureus (1, 2). In addition to FASII,
pathogens can readily acquire fatty acids from their environment through either the FakAB
system (Gram-positive bacteria) (3) or FadL (Gram-negative bacteria) (4, 5), which may render
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them resistant to FASII-targeting antimicrobial strategies, as illustrated in S. aureus (6, 7).
Nevertheless, S. aureus fatty acid auxotrophs are avirulent in a mouse model of disease (8),
indicating that at least some level of de novo synthesis is critical for bacterial survival during
infection. Interestingly, the balance between de novo fatty acid synthesis and exogenous ac-
quisition has never before been studied in Gram-negative bacterial pathogens. Furthermore,
the niche specificity of bacterial lipid homeostasis is poorly understood.
We defined the fatty acid compositions of various mouse niches and their changes
following intranasal challenge with the Gram-negative human pathogen Acinetobacter
baumannii (strain AB5075_UW) (see Text S1 in the supplemental material). Overall, the
fatty acid abundance in mouse plasma decreased following infection, with the most dra-
matic changes being seen in 16:0, 18:1, and 18:2 species (Fig. 1a). In contrast, 20:4 was
not affected by A. baumannii infection, potentially due to a role in immune activation,
findings consistent with those in mice infected with Streptococcus pneumoniae (9). The
liver is the primary site of host fatty acid synthesis, and its profiling revealed the most
FIG 1 The host and A. baumannii lipid landscape. (a to d) The fatty acids (milligrams of fatty acid per milliliter or gram of tissue) in the plasma (a), liver
tissue (b), bronchoalveolar lavage (BAL) fluid (c), and pleural lavage (PL) fluid (d) of 9-week-old female BALB/c mice were examined prior to (Naïve) and
24 h after (Infect) intranasal challenge with A. baumannii strain AB5075_UW. Statistical analyses were performed using one-way analysis of variance
(ANOVA) (Bonferroni test). *, P# 0.05; **, P# 0.01; ***, P# 0.001; ****, P# 0.0001. (e to h) The phosphatidylethanolamine (PE) (e and g) and
phosphatidylglycerol (PG) (f and h) species (number of carbons:number of double bonds in the acyl chains) were quantified in A. baumannii cultured in
Luria-Bertani (LB) or M9 medium or A. baumannii from the pleural lavage fluid of BALB/c mice 24 h after intranasal challenge, using liquid chromatography-
mass spectrometry (LC-MS). (i to l) LC-MS chromatograms for heavily enriched lipid species in A. baumannii isolated from the PL fluid (PE 36:3 [i] and PG
34:3 [j]) and control lipid species present in A. baumannii from the PL fluid and those cultured in LB medium (PE 36:2 [k] and PG 36:2 [l]). The PL fluid from
uninfected mice (PL2) is included as a control (no discernible signal). The data represent the averages from 4 biological replicates. (m) The relative number
of double bonds of PE and PG species in A. baumannii from LB or M9 media, or the PL fluid was defined using the percent abundance. All statistical
analyses in panels e to h and m were performed by one-way ANOVA (Bonferroni test), with different letters denoting statistical significance between
samples, per phospholipid species.
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pronounced increases in 18:1 and 18:2 (Fig. 1b), possibly to replenish their deficit
observed in plasma. The bronchoalveolar lavage (BAL) fluid represents the primary bac-
terial challenge site, where 16:0 is the predominant fatty acid (Fig. 1c). The 16:0 abun-
dance decreased marginally following infection, whereas that of 18:1 increased. Finally,
we assayed the pleural lavage (PL) fluid, a sterile niche in uninfected animals, with fatty
acid levels below the limit of detection (Fig. 1d). A. baumannii colonization resulted in
the subsequent identification of 16:0, 18:2, 18:0, 18:1, and 20:4 species (in order of abun-
dance). Similar to that observed in mouse plasma, the increase in 20:4 in the PL fluid
may be due to a contribution to immune modulation. Overall, these findings indicate
that A. baumannii necessitates adaptation to vastly different lipid landscapes when colo-
nizing distinct host niches. The changes in the fatty acid profiles in these niches follow-
ing infection may be a result of the host response to infection, in combination with the
bacterium acquiring and secreting fatty acids during proliferation.
To ascertain the potential exchange of fatty acids between A. baumannii and the host
environment, we analyzed the lipidome of A. baumannii isolated from the pleural cavity
and compared it to that of A. baumannii cultured in Luria-Bertani (LB) medium or M9
minimal medium (Text S1). Unlike the BAL fluid, the PL fluid is sterile in uninfected ani-
mals, which eliminates the contamination of the sample by non-A. baumannii bacterial
species. Furthermore, as the level of A. baumannii colonization in this niche is high (.109
CFU per sample), there is no need for tissue disruption or the removal of erythrocytes,
and host immune cells can easily be depleted from the lavage fluid via centrifugation
(Text S1). We studied the most abundant A. baumannii phospholipids, phosphatidyletha-
nolamine (PE) and phosphatidylglycerol (PG), by liquid chromatography-mass spectrom-
etry (LC-MS) (Fig. 1e and f). The analysis of A. baumannii cultured in M9 medium revealed
that the bacterium does not readily synthesize phospholipids with acyl chains that har-
bor multiple double bonds (Fig. 1g and h). Examples of these phospholipid species with
polyunsaturated acyl chains, which were most likely host acquired, include PE 36:3 (18:1
plus 18:2; 5.6 103-fold increase [PL fluid as compared to M9 medium]), PE 36:4 (16:0
plus 20:4; 1.8 104-fold increase [PL fluid as compared to M9 medium]), PG 34:3 (16:0
plus 18:2; 1.5 103-fold increase [PL fluid as compared to M9 medium]), and PG 36:3
(18:1 plus 18:2; 9.1 102-fold [PL fluid as compared to M9 medium]) (Fig. 1g and h).
These data are consistent with the relative abundances of 18:2 and 20:4 in the PL fluid
(Fig. 1d). Furthermore, we previously reported that 20:4 is preferentially incorporated
into the PE pool of A. baumannii, with 16:0 occupying the other position on the phos-
pholipid, thereby generating PE 36:4 (10). Similarly, A. baumannii cultured in the pres-
ence of 18:3 combines this exogenous fatty acid with 16:0 to generate PE 34:3 (11). To
illustrate that the bacterial isolation procedure eliminated eukaryotic contamination, we
compared the LC-MS signal intensities of LB medium-cultured cells and the PL fluid sam-
ples of infected and uninfected mice (Fig. 1i to l). In particular, we interrogated the spe-
cies that were present in a high abundance in A. baumannii from PL fluid samples (Fig. 1i
and j) and those of similar abundances between in vitro and in vivo A. baumannii cells
(Fig. 1k and l). Noteworthy, PG 34:3 (16:1 plus 18:2) and PG 36:3 are unusual species not
commonly found in mammalian cells (LipidMAPS database) (12, 13) or in A. baumannii
grown in LB or M9 medium (Fig. 1j) (10). Hence, its presence in A. baumannii isolated
from the mouse pleural cavity is a strong indicator of A. baumannii 18:2 acquisition from
the host, reminiscent of 18:1 acquisition by S. aureus in mouse thigh tissue (14). The
enhanced incorporation of 18:2 fatty acids in the A. baumannii PE and PG pools affected
the total number of unsaturated fatty acids in A. baumannii from the PL fluid, by 1.4- and
1.3-fold (PE) and 1.04- and 1.06-fold (PG) compared to those cultured in M9 and LB
media, respectively (Fig. 1m).
To study the relative contribution of fatty acid acquisition to A. baumannii virulence,
we challenged mice intranasally with wild-type AB5075_UW and a fadL mutant deriva-
tive (A. baumannii fadL::T26) and compared their invasion in diverse niches. The fadL
mutant was significantly impaired in the colonization of the bronchoalveolar lumen,
lung tissue, pleural cavity, liver, and spleen, ranging from 6.5 102-fold (BAL fluid) to
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2.0 104-fold (PL fluid) (Fig. 2a). In contrast, colonization of the fadL mutant was only
marginally lower from that of the wild type in the blood (1.6 101-fold). Although
these phenotypes are most likely related to the role in fatty acid acquisition, FadL is a
surface-exposed protein that has also been shown to play a role in adherence to host
cells in Haemophilus influenzae (15). Hence, from these data alone, we cannot rule out
a multifactorial cause behind the observed colonization differences.
To delineate the role of exogenous fatty acid acquisition relative to de novo synthesis, we
examined the transcription levels of fadL and fabG (a critical FASII member) in A. baumannii
from the BAL fluid, PL fluid, and blood (Text S1 and Table S1). Overall, fadL transcription lev-
els were similar in distinct host niches (Fig. 2b). Although the fabG expression level was sig-
nificantly higher in A. baumannii from the PL fluid than from the BAL fluid (1.8-fold), the
fabG transcription level was 17-fold higher in A. baumannii from the blood than from the PL
fluid (Fig. 2c). In combination with FadL being nearly superfluous during A. baumannii bac-
teremia, this is a strong indicator that A. baumannii relies heavily upon de novo fatty acid
synthesis while residing in the blood. In other niches, A. baumannii is likely to augment the
intracellular pool of fatty acids with exogenously acquired fatty acids through uptake via
FadL. To gain greater insights into the intracellular A. baumannii lipid status, we also assayed
the expression of fadB (a critical component of the b-oxidation pathway), as its expression in
A. baumannii is associated with an intracellular fatty acid surplus (10). Interestingly, whereas
fadB expression levels in A. baumanniiwere comparable in the PL and BAL fluids, in the blood,
expression decreased by approximately 700-fold (Fig. 2d). This is consistent with A. baumannii
experiencing fatty acid limitation and relying upon synthesizing its own fatty acids in this
niche. Transcriptional profiling of fadL, fabG, and fadB in A. baumannii cultured in LB medium
indicated that the bacterium balances de novo synthesis and fatty acid uptake/recycling when
grown in this medium, as it was analogous to that observed in A. baumannii in the PL fluid
(Fig. 2b to d). Noteworthy, FadL has been shown to play roles other than in the acquisition of
exogenous fatty acids to supplement the bacterial membrane. For example, in Salmonella
enterica, FadL-mediated fatty acid acquisition influences the expression of the pathogenicity
island 1 type III secretion system (16). Furthermore, FadL has been shown to exert dual roles in
Haemophilus influenzae, these being fatty acid acquisition and host cell adherence (15).
Conclusions. A. baumannii is an opportunistic pathogen with limited host adaptation
traits. Here, we have illustrated that A. baumannii utilizes environmental fatty acids to pro-
mote colonization in various niches of the host, which include nonself fatty acids, such as
18:2, to generate a unique phospholipid profile. Host fatty acid profiling revealed a decrease
in most fatty acid species in the plasma following infection with A. baumannii. This could be
a host-mediated response to infection or depletion due to A. baumannii acquisition during
the early stages of bacteremia. However, the relative competitiveness of the fadL mutant
FIG 2 The niche-specific balance between fatty acid acquisition and de novo synthesis. (a) The role of FadL-
mediated fatty acid acquisition in A. baumannii colonization was examined following intranasal challenge of 9-
week-old female BALB/c mice with 3 108 CFU of A. baumannii AB5075_UW (wild type) and the fadL mutant
(fadL::T26). The differences between the two groups (geometric means) are indicated with gray bars. Statistical
analyses were performed using one-way ANOVA (Bonferroni test). **, P# 0.01; ****, P# 0.0001. (b to d) The
gene expression levels of fadL (b), fabG (c), and fadB (d), corrected against those defined for rpoB, in A.
baumannii AB5075_UW cultured in Luria-Bertani (LB) medium or isolated from the bronchoalveolar lavage (BAL)
fluid, pleural lavage (PL) fluid, or blood were examined by quantitative reverse transcription-PCR (qRT-PCR). The
dotted lines indicate the limits of detection (a and d). All statistical analyses were performed using one-way
ANOVA (Bonferroni test). *, P# 0.05; ***, P# 0.001; ****, P# 0.0001.
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compared to the wild type in the blood suggests the former. Despite the relatively high
abundance of fatty acids in the plasma, these do not appear to be bioavailable to A. bau-
mannii, potentially as a result of sequestration by plasma lipid binding proteins such as albu-
min and low/high-density lipoproteins. Fatty acid synthesis is an attractive target for the de-
velopment of new antimicrobial strategies, and our work has underscored the critical need
to understand microbial lipid homeostasis before this can be deemed suitable. Overall,
FASII-targeting antibiotics are likely to be most effective against A. baumannii bloodstream
infection.
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